REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/26/2026
Back to search
Official data from USPTO
GLUCAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/26/2026
Trademark type
Word
Nice classes
5
Filing date
09/28/2006
Registration date
06/26/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2017
Last transaction
06/26/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1999-08-00
First use in commerce
1999-08-00
Drawing code
4
Owner type
65
Owner location
DK-2880 Bagsvaerd, DK
Examiner
MCBRIDE, THEODORE M
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Novo Nordisk A/S
Novo Nordisk A/S
Representatives
Claudia A. Smith White & Case LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations namelyglucagon preparations for diagnostic and therapeutic indications
Publications
History of USPTO decisions and trademark events.
35 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/13/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/13/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/13/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/27/2016
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
12/13/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/13/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
10/04/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/26/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2013
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/13/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/13/2013
E815
TEAS SECTION 8 & 15 RECEIVED
03/11/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2011
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/19/2008
PLGL
ASSIGNED TO PARALEGAL
06/09/2008
AMD7
SEC 7 REQUEST FILED
05/06/2008
PAPER RECEIVED
05/06/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2007
PUBO
PUBLISHED FOR OPPOSITION
04/10/2007
NPUB
NOTICE OF PUBLICATION
03/21/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/21/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/20/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2007
ALIE
ASSIGNED TO LIE
02/20/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2007
GNRT
NON-FINAL ACTION E-MAILED
11/20/2006
CNRT
NON-FINAL ACTION WRITTEN
11/20/2006
DOCK
ASSIGNED TO EXAMINER
11/13/2006
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/23/2006
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/23/2006
NWAP
NEW APPLICATION ENTERED
10/03/2006
Continuous trademark protection
Get notified about every new filing that threatens GLUCAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.